China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion

Reuters

07/22

China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion

China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2553259742"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553259742\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553259742?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-22 21:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553259742","market":"us","top_or_hot":-1,"title":"China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-22 21:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1511","symbol_name":"疑似財技股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL9mF8wz:1","article_id":"2553259742","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553259742","pubTimestamp":1753192581,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT striv","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1511":"疑似财技股","BK1219":"保健护理服务","08037":"中国生物科技服务"},"translate_title":"中国生物科技服务控股有限公司提供解决无法发表意见的行动计划季度更新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":0.9},"content_text":"China Biotech Services Holdings Ltd. Provides Quarterly Update on Action Plan to Resolve Disclaimer of Opinion\n    \n\n        China Biotech Services Holdings Ltd. has provided a quarterly update on the implementation of its action plan to address the disclaimer of opinion regarding going concern raised by its auditors for the year ended 31 December 2024. The company has made progress with its financing projects, which are expected to exceed RMB150 million in aggregate. Several projects are currently undergoing due diligence or awaiting internal approval by investors. The board continues to actively implement the action plan, aiming to resolve the disclaimer as soon as possible. Additionally, the management has successfully renewed a bank borrowing of RMB4,000,000, equivalent to approximately HK$4,388,000. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares. Further updates on the implementation progress will be published as appropriate.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief on July 22, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}